Bringing Better Treatment for Gynecologic Cancer with MRI Guidance
NCT02993900 · RecruitingThis study looks at how MRI can help doctors place a treatment device called a brachytherapy applicator for gynecologic cancers. It aims to see if MRI does a better job than CT scans in guiding treatment. The goal is to improve treatment effectiveness while reducing radiation exposure to healthy tissue.
Locations and contact
This trial is running at 1 location in the United States. It is currently recruiting.
United States1 location · 1 recruiting
- The SKCCC at Johns HopkinsBaltimore, MarylandRecruiting
Who can join
This trial is open to women aged 18 to 100 who have confirmed gynecologic cancer. Participants should be eligible for internal treatment without MRI guidance. Patients with prior radiation or chemotherapy can join. A life expectancy of more than 6 months is needed, along with the ability to understand and sign consent forms. Medical conditions that could interfere with participation may exclude some individuals. The trial team will confirm eligibility.
What happens during the trial
Everyone in the trial will receive MRI-guided brachytherapy. This means that doctors will use MRI to help place the brachytherapy device accurately. There are no separate groups; all participants will experience the same treatment.
The trial team
The trial is sponsored by the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, with Dr. Akila Viswanathan as the principal investigator. The National Cancer Institute is also collaborating on this study.
Important dates
The trial started on December 15, 2016, and is currently recruiting participants. It is expected to finish by December 2028, with the primary completion date set for December 2026.
Additional information
The trial's ID number is NCT02993900. It is not currently in any specific phase. The study is not regulated by the FDA for drugs or devices. The goal is to enroll about 54 participants.
Other recruiting trials for the same condition, with the eligibility rules written in plain language.
Browse similar trials →Find a top oncologist who can tell you whether a trial is a sensible option for you.
Find a doctor →The cancer centers running studies like this one, and what each is known for.
Browse hospitals →